Nature's Toolbox (NTx)

Nature's Toolbox, Inc. (NTx) develops domestically-sourced biomanufacturing solutions for personalized therapeutics and biologics. Their innovative systems, like NTxpress® and NTxscribe®, enable eco-friendly and sustainable manufacturing of mRNA vaccines and protein therapeutics, scaling from personalized medicine to pandemic volumes. This addresses challenges in conventional manufacturing processes and supply chain instability.

Funding Round: Venture Debt

Funding Amount: $15M

Date: 04-Dec-2024

Investors: J.P. Morgan

Markets: Biomanufacturing, Life Sciences, Biotechnology, Early-Stage Drug Development, Antibiotics, Small Molecule Drugs, Cell Free Synthesis, Biosimilars, Natural Products, Vaccines, Oncology, Immunology, Biologics, Pharma, Personalized Medicine, mRNA

HQ: Rio Rancho, New Mexico, United States

Founded: 2015

Website: https://ntxbio.com/

LinkedIn: https://www.linkedin.com/company/ntxbio

Twitter: https://twitter.com/NaturesToolbox_

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/ntxbio

Pitchbook: https://pitchbook.com/profiles/company/222844-60